• Mia Bennett posted an update in the group Group logo of HealthHealth 5 years ago

    It Is Cool That A New Gene Therapy Drug, Zolgensma, Has Been Developed, Which Can Possibly Cure Spinal Muscular Atrophy (SMA), A Muscle-Wasting Disease That Often Kills Babies Before The Age 2. The Drug, Which Is Expected To Receive US FDA Approval This May 2019, Could Cost As Much As $2 million /Treatment. Another Pricey Drug.